Rupin Singh, MD
- Specialty: Neurology-Epilepsy, Neurology
-
Location:UH Cleveland Medical Center Bolwell
11100 Euclid Ave
Cleveland, OH 44106
- Call: 216-844-3192
Biography: Rupin Singh, MD
Expertise
Certifications & Memberships
- Neurology - American Board of Psychiatry and Neurology
Education
Fellowship | Epilepsy/EEG
Epilepsy/EEG - UH Cleveland Medical Center (2023 - 2024)
Residency | Neurology
Neurology - University Of Central Florida College Of Medicine (2019 - 2023)
Medical Education
University Of South Florida College Of Medicine (2019)
Undergraduate
University Of South Florida (2016)
About
Dr. Rupin Singh, MD is a board certified neurologist and an Assistant Professor in Neurology at University Hospitals Cleveland Medical Center. He specializes in the treatment of patients with epilepsy and EEG monitoring. His clinical and research interests include the treatment of patients with drug-resistant epilepsy, surgical epilepsy, seizure semiology, and medical education.
Dr. Singh grew up in Jacksonville, Florida and completed his medical education at the University of South Florida (USF) followed by a four-year residency in neurology at the University of Central Florida (UCF) and a fellowship in epilepsy at University Hospitals.
He strives to provide excellent education to medical students and residents. In doing so, Dr. Singh was awarded the resident teacher award and clinical skills award from the UCF Neurology Residency program. He also served as chair of the Resident Wellness Committee during which he directed numerous activities to improve resident mental health and wellbeing.
Dr. Singh is a member of various national societies including the American Academy of Neurology (AAN) and the American Epilepsy Society (AES). During his fellowship, he was selected to participate in the AES Fellows Program. In his free time, Dr. Singh enjoys hiking with his wife and corgi, baking, and fermentation.
Research & Publications
Research Interests
Epilepsy, Epilepsy Surgery, Seizure semiology, Medical education
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Rupin Singh did not disclose any Outside Relationships with Industry.